Pak Fah Yeow International Limited (0239) AI Stock Analysis

• Market Cap: HK$757.29M
• Dividend Yield: 7.52%
• Average Volume (3M): 22.62K
• Price to Earnings (P/E): 10.7
• Beta (1Y): -0.10
• Revenue Growth: -24.96%
• EPS Growth: -26.43%
• Country: HK
• Employees: 106
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.13
• Shares Outstanding: 311,640,000
• 10 Day Avg. Volume: 26,750
• 30 Day Avg. Volume: 22,616
• PEG Ratio: -0.37
• Price to Book (P/B): 1.06
• Price to Sales (P/S): 3.26
• P/FCF Ratio: 9.91
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 74 Outperform
• Price Target: HK$2.50 ▲(0.81% Upside)

The overall stock score of 74 reflects a strong valuation with an attractive dividend yield and a stable technical outlook. However, financial performance is mixed due to declining revenue and net profit margins, and the lack of complete cash flow data limits a full assessment of liquidity.

Pak Fah Yeow International Limited Business Overview & Revenue Model

Company Description

Pak Fah Yeow International Limited (0239) is a Hong Kong-based company primarily engaged in the manufacture and distribution of healthcare products. The company is best known for its flagship product, White Flower Embrocation, a medicated oil used for relief of minor aches and pains. The company operates in the healthcare sector and has a strong presence in both local and international markets, focusing on high-quality, traditional medicinal products.

How the Company Makes Money

Pak Fah Yeow International Limited generates revenue primarily through the sales of its healthcare products, with White Flower Embrocation being the core product. The company distributes its products through a network of wholesalers, retailers, and direct sales channels, both domestically in Hong Kong and internationally. Key revenue streams include product sales to distributors and retailers in various countries, direct consumer sales, and licensing agreements for product distribution. The company's revenue is significantly influenced by its brand reputation, product efficacy, and the expansion of its distribution network. Partnerships with local distributors in international markets also play a crucial role in driving sales outside of Hong Kong.

Pak Fah Yeow International Limited Financial Statement Overview

Summary

Pak Fah Yeow International Limited shows a stable financial structure with strong profitability margins and low leverage. However, declining revenue and net profit margins indicate potential operational challenges. The absence of complete cash flow data for 2024 limits a full assessment of liquidity and cash management capabilities.

Income Statement

The company demonstrated a mixed financial performance. While the EBIT margin was strong at 41.42% and EBITDA margin at 56.19% in 2024, the net profit margin declined to 33.11% from 40.50% in 2023. Revenue in 2024 showed a negative growth rate of -8.43% compared to 2023, indicating challenges in maintaining revenue growth.

Balance Sheet

The balance sheet is robust, with a low debt-to-equity ratio of 0.01, indicating minimal leverage. The equity ratio stands at a healthy 86.77%, reflecting strong asset backing. However, the return on equity decreased to 10.75% in 2024 from 13.73% in 2023, showing a decline in profitability on equity.

Cash Flow

Cash flow analysis is limited due to missing data for 2024. In 2023, the operating cash flow to net income ratio was 1.41, indicating efficient conversion of profits into cash flow. Free cash flow growth was not calculable for 2024 due to unavailable data, presenting a challenge in assessing cash flow trends.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	199.54M	236.91M	259.31M	147.20M	139.82M	109.34M
Gross Profit	173.45M	203.20M	167.59M	74.06M	68.71M	41.48M
EBITDA	105.12M	105.73M	136.81M	45.90M	54.67M	-25.22M
Net Income	70.97M	78.63M	105.04M	29.95M	38.19M	-38.36M
Balance Sheet
Total Assets	852.25M	843.35M	907.47M	823.14M	837.75M	795.40M
Cash, Cash Equivalents and Short-Term Investments	365.20M	290.02M	277.61M	180.34M	178.28M	131.48M
Total Debt	4.79M	4.20M	4.74M	5.50M	16.21M	17.86M
Total Liabilities	148.07M	111.45M	142.28M	115.91M	130.03M	122.20M
Stockholders Equity	704.18M	731.91M	765.18M	707.23M	707.72M	673.19M
Cash Flow
Free Cash Flow	57.39M	78.02M	144.84M	39.76M	69.54M	7.62M
Operating Cash Flow	57.94M	78.96M	147.90M	39.92M	70.36M	8.26M
Investing Cash Flow	2.37M	-3.19M	16.65M	-6.67M	-565.00K	-637.00K
Financing Cash Flow	-66.91M	-67.54M	-48.96M	-33.91M	-22.41M	-29.07M

Pak Fah Yeow International Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2.48
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0239, the sentiment is Positive. The current price of 2.48 is above the 20-day moving average (MA) of 2.42, above the 50-day MA of 2.40, and above the 200-day MA of 2.29, indicating a bullish trend. The MACD of 0.02 indicates Negative momentum. The RSI at 66.02 is Neutral, neither overbought nor oversold. The STOCH value of 93.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0239.

Pak Fah Yeow International Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8049	78 Outperform	€1.20B	6.10	11.38%	―	10.26%	6.24%
0239	74 Outperform	HK$757.29M	10.67	9.75%	7.52%	-24.96%	-26.43%
3737	63 Neutral	HK$508.20M	22.81	1.87%	8.33%	-1.99%	-81.52%
0897	55 Neutral	HK$489.42M	69.05	0.55%	6.90%	-4.92%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
1652	49 Neutral	HK$610.24M	―	-40.38%	―	-43.46%	-96.48%
1498	45 Neutral	HK$213.98M	-4.10	-33.22%	―	-17.32%	55.74%

Pak Fah Yeow International Limited Corporate Events

Pak Fah Yeow Announces Interim Dividend for 2025

Pak Fah Yeow International Limited has announced an interim dividend of HKD 0.03 per share for the six months ending June 30, 2025. The ex-dividend date is set for September 29, 2025, with the payment scheduled for December 5, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may influence investor sentiment positively.

The most recent analyst rating on (HK:0239) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Pak Fah Yeow International Limited stock, see the HK:0239 Stock Forecast page.

Pak Fah Yeow Announces Special Interim Dividend for 2025

Pak Fah Yeow International Limited has announced a special interim dividend of HKD 0.05 per share for the six months ending June 30, 2025. The ex-dividend date is set for September 29, 2025, with the payment scheduled for December 5, 2025. This announcement reflects the company’s financial health and commitment to returning value to its shareholders.

The most recent analyst rating on (HK:0239) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Pak Fah Yeow International Limited stock, see the HK:0239 Stock Forecast page.

Pak Fah Yeow Reports Decline in H1 2025 Financials Amid Healthcare Sales Drop

Pak Fah Yeow International Limited reported a significant decline in its financial performance for the first half of 2025, with revenue and underlying recurring profit decreasing by 28.5% and 26.6% respectively, mainly due to reduced sales in its healthcare business. Despite lower reported profits and fair value losses on investment properties, the company declared an interim dividend and a special interim dividend, indicating a commitment to shareholder returns amidst challenging market conditions.

The most recent analyst rating on (HK:0239) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Pak Fah Yeow International Limited stock, see the HK:0239 Stock Forecast page.

Pak Fah Yeow Declares Interim and Special Dividends for 2025

Pak Fah Yeow International Limited has announced an interim dividend of HK3.0 cents per share and a special interim dividend of HK5.0 cents per share for the year ending 31 December 2025. This decision reflects the company’s commitment to rewarding its shareholders and may positively impact its market perception and shareholder relations.

The most recent analyst rating on (HK:0239) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Pak Fah Yeow International Limited stock, see the HK:0239 Stock Forecast page.

Pak Fah Yeow International Limited Schedules Board Meeting for Interim Results

Pak Fah Yeow International Limited has announced that its board of directors will meet on August 21, 2025, to approve the interim results for the first half of the year ending June 30, 2025, and to consider the payment of an interim dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial health and potential returns on investment, reflecting its operational performance and strategic positioning in the market.

Pak Fah Yeow Issues Profit Warning for H1 2025

Pak Fah Yeow International Limited has issued a profit warning, indicating an expected decrease in consolidated net profit for the first half of 2025 to approximately HK$39.7 million, down from HK$47.4 million in the same period of 2024. This decline is primarily due to a reduction in total revenue, although it is partially offset by a decrease in unrealised fair value loss on investment properties and reduced tax expenses. Despite the profit drop, the company’s financial position remains healthy.